Psychedelic drug developer Diamond Therapeutics picks up funding

Toronto-based Diamond Therapeutics is a drug development company focused on psychedelic-derived therapies for use in the treatment of mental health.

10 April 2023•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.